Thank you for the question Nidan. Would it be ok if I put an answer together Friday next week :-)
I do have a sense that SP will rise as the market recognise and can estimate readout timing, I think especially from the PDD trial.
Let’s see. Thursday there should be a likely meaningful update on enrolment progress that might surprise some.
I have my doubts on the partnership front at this time mainly because as far as we can tell Missling is keen to push that out till after positive trial results with commercialisation in sight. My take is that the preferreds are with that in mind.